Fred Hutch Lands $4M for HTS-Driven Stratified Cancer Studies | GenomeWeb

NEW YORK (GenomeWeb News) – Investigators at the Fred Hutchinson Cancer Research Center will use a $4 million award from the National Cancer Institute to identify new classes of drug targets and develop criteria for stratifying patients based on who will benefit from those new therapeutics, the center said on Tuesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.